Hemoglobin glycation index as a useful predictor of therapeutic responses to dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes - Chen, Yu-Wei; Wang, Jun-Sing; Sheu, Wayne H-H; Lin, Shih-Yi; Lee, I-Te; Song, Yuh-Min; Fu, Chia-Po; Lee, Chia-Lin (PloS one, 2017)
Keywords: Adamantane - analogs & derivatives; Adamantane - therapeutic use; Adult; Aged; Analysis; Biology and life sciences; Biomarkers, Pharmacological - blood; Blood Glucose - drug effects; Care and treatment; Diabetes; Diabetes mellitus; Diabetes mellitus (non-insulin dependent); Diabetes Mellitus, Type 2 - blood; Diabetes Mellitus, Type 2 - diagnosis; Diabetes Mellitus, Type 2 - drug therapy; Dipeptides - therapeutic use; Dipeptidyl-peptidase IV; Dipeptidyl-Peptidase IV Inhibitors - therapeutic use; Endocrinology; Fasting; Female; Glucose; Glycated Hemoglobin - analysis; Glycated Hemoglobin - metabolism; Glycemic index; Glycosylated hemoglobin; Glycosylation; Health aspects; Health Status Indicators; Hemoglobin; Hospitals; Humans; Inflammation; Inhibitors; Internal medicine; Linagliptin - therapeutic use; Male; Medicine; Medicine and health sciences; Metabolism; Middle Aged; Nitriles - therapeutic use; Patients; Peptidase; Physical Sciences; Predictive Value of Tests; Prognosis; Public health; Pyrrolidines - therapeutic use; Retrospective Studies; Risk factors; Sitagliptin Phosphate - therapeutic use; Systematic review; Treatment Outcome; Type 2 diabetes; Vildagliptin; Japan; Taiwan